Meritech Capital is a provider of late-stage venture capital to information and medical technology companies. Their investments are typically in mature companies with proven and differentiated technology, rapidly-growing revenue, and seasoned management teams. As a late stage investor, they provide guidance to our portfolio companies on issues specific to maturing private companies including management incentive plans, IPO market timing and positioning, liquidity, adviser selection, and public company governance, audit and other similar requirements.